Figure 4From: DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1 Ovarian cancer cell lines do not express high levels of DcR3 protein binding partners. The cell lines studied do not express the protein ligands for DcR3 (except for low levels of cell surface LIGHT) to account for the binding pattern seen in Figure 3A.Back to article page